Drug Type Small molecule drug |
Synonyms (-)-mequitazine, (S)-mequitazine, L-mequitazine + [4] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22N2S |
InChIKeyHOKDBMAJZXIPGC-INIZCTEOSA-N |
CAS Registry88598-74-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rhinitis, Allergic, Perennial | Phase 3 | Austria | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Czechia | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Estonia | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Finland | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Latvia | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Lithuania | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | Spain | - | |
| Rhinitis, Allergic, Perennial | Phase 3 | United Kingdom | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | Belgium | - | |
| Rhinitis, Allergic, Seasonal | Phase 3 | Czechia | - |





